WHO ICTRP trial
First in Human study of FixTA Endovasular Stentgraft for Aortic arch
ChiCTR2600118404 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2600118404 |
|---|---|
| Public title | First in Human study of FixTA Endovasular Stentgraft for Aortic arch |
| Scientific title | First in Human study of FixTA Endovasular Stentgraft for Aortic arch - FIESTA-I Study |
| Primary sponsor | Beijing Anzhen Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | aortic dissection, aortic pseudoaneurysm, aortic rupture |
| Interventions | Test group:FixTA Tri-Branch |
| Registration date | Feb 5, 2026 |
| Target size | Test group:102 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: